- Location
Oral Therapy
"-
Probiotic Treatment Potential for a Long Term Cure for Peanut Allergies to Be Developed
Jan 29, 2015A probiotic treatment for peanut allergy has been successfully trialled by Australian researchers at the Murdoch Children’s Research Institute. The researchers said their findings showed that there was potential for a long term cure ...
-
Gilead Obtained Priority Review Status for Sofosbuvir New Drug Application
Jun 13, 2013Biopharmaceutical company Gilead Sciences has obtained priority review status for Sofosbuvir new drug application (NDA) from the FDA for the treatment of hepatitis C infection (HCV). The investigational product is an oral nucleotide ...
Tags: Gilead, Sofosbuvir NDA
-
The FDA Has Cleared Celgene's sNDA for Revlimid for Refractory Mantle Cell Lymphoma
Jun 7, 2013The FDA has cleared Celgene's supplemental new drug application (sNDA) for Revlimid (lenalidomide) for the treatment of patients with relapsed or refractory mantle cell lymphoma (MCL). The approval follows positive data from MCL-001 phase ...
-
FDA Has Approved Janssen's Invokana for The Treatment of Adults
Apr 2, 2013The US food and drug administration (FDA) has approved Janssen's Invokana (canagliflozin) for the treatment of adults with type 2 diabetes. Invokana is the oral, once-daily medication available in the US demonstrating improved glycemic ...
-
The European Commission Will Review CHMP's Positive Opinion
Dec 4, 2012Pfizer has received positive opinion from the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency for the marketing authorization of axitinib to treat patients with advanced renal cell carcinoma. The European ...
-
EC Has Granted Marketing Authorization to Pfizer's INLYTA (Axitinib) Oral Therapy
Dec 4, 2012The European Commission (EC) has granted marketing authorization to Pfizer's INLYTA (axitinib) oral therapy, designed to treat adult patients with advanced renal cell carcinoma (RCC). INLYTA, a kinase inhibitor, is designed to ...
-
Fresenius Kabi USA Has Announced The Availability of Acetylcysteine Solution, USP
Nov 29, 2012Fresenius Kabi USA has announced the availability of Acetylcysteine Solution, USP, 20% 30ml vial for inhalation (mucolytic agent) or oral administration (acetaminophen antidote) to treat lung diseases. Acetylcysteine Solution, USP, ...
Tags: Acetylcysteine Solution, lung diseases, critical care products
-
Bedford Laboratories Has Issued a Nationwide Voluntary Hospital/User-Level
Nov 28, 2012Bedford Laboratories has issued a nationwide voluntary hospital/user-level recall of certain lots of leucovorin calcium injection due to the discovery of visible crystalline particulate matter in a small number of vials. The particulate ...
-
Sagent Pharmaceuticals Has Introduced a Folic Acid Derivative Therapy
Nov 28, 2012Sagent Pharmaceuticals has introduced a folic acid derivative therapy, designed to treat megaloblastic anemias patients who are not responding to oral therapy. The new Leucovorin Calcium for Injection is indicated for rescue after ...
-
Pernix Presentations Triple Combination Oral Therapy to Treat H. Pylori Infection
Nov 28, 2012Pernix Therapeutics, a specialty pharmaceutical company, has announced the availability of Omeclamox-Pak to treat Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in ...
Tags: Oral Therapy, Omeclamox-Pak, H.pylori
Related Products
-
Dental New Products Reciprocating Interproximal Strip Disposable Contra Angle Set Ipr Kit 4: 1
-
with 10 PCS Strips Hand Use Dental Orthodontics Ipr System/Orthodontic Reciprocating Tools 4: 1 Disposable Handpiece
-
Dental Reduction Ipr System/ Interproximal Stripping Kits/Orthodontic Tools Reciprocating
-
Factory Price Dental Ipr System 4: 1 Contra Angle for Machine Use / Orthodontic Tools
-
Plastic Dappen Dish for Oral Therapy Equipments
-
Oral Therapy Plastic Dappen Dish for Dental and Nail Treatments
